Drug intelligence / Profile preview

liposome bupivacaine (bupivacaine liposome)

Development stage
Approved
Lead developer
Pacira BioSciences
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Parenteral
01

Overview

Bupivacaine liposome is a long-acting local anesthetic formulation consisting of bupivacaine encapsulated in multivesicular liposomes using DepoFoam technology. It is designed for single-dose administration into the surgical site to provide prolonged postsurgical analgesia by slowly releasing bupivacaine over an extended period, typically up to 72 hours. As an amide-type local anesthetic, it works by blocking voltage-gated sodium channels on the neuronal membrane, preventing the generation and conduction of nerve impulses. It was developed by Pacira BioSciences and is widely used for various surgical procedures to reduce the need for systemic opioids.

Brand names
Exparel
Other names
liposomal bupivacaineliposome bupivacainebupivacaine liposome injectable suspension
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)SCN5A (Sodium channel protein type 5 subunit alpha)CaV (Voltage-gated calcium channel protein complex)Kir (Inward-rectifier potassium channels)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on liposome bupivacaine (bupivacaine liposome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liposome bupivacaine (bupivacaine liposome).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call